These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1907104)

  • 1. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F108-16. PubMed ID: 1907104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor is a renal vasodilator in the anesthetized rat.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1990 Jun; 258(6 Pt 2):F1504-9. PubMed ID: 2360650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs.
    Takahara A; Suzuki-Kusaba M; Hisa H; Satoh S
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):966-70. PubMed ID: 1704991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.
    Bauer J; Parekh N
    Kidney Int; 2003 Jun; 63(6):2178-86. PubMed ID: 12753305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.
    Schwertschlag U; Scherf H; Gerber JG; Mathias M; Nies AS
    Circ Res; 1987 Apr; 60(4):534-9. PubMed ID: 3297384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
    Baer PG; Cagen LM
    Hypertension; 1987 Mar; 9(3):253-60. PubMed ID: 3818022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor and solute transport processes in the kidney.
    Handa RK; Strandhoy JW; Giammattei CE; Handa SE
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F274-81. PubMed ID: 12529272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
    Haynes J; Chang SW; Morris KG; Voelkel NF
    J Appl Physiol (1985); 1988 Nov; 65(5):1921-8. PubMed ID: 3209541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension.
    Feng JJ; Arendshorst WJ
    Hypertension; 1997 Nov; 30(5):1223-31. PubMed ID: 9369280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors.
    Cooper CL; Shaffer JE; Malik KU
    Circ Res; 1985 Jan; 56(1):97-108. PubMed ID: 3917874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1984 Apr; 229(1):139-47. PubMed ID: 6423810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
    Barrett RJ; Droppleman DA
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Ca++ and calmodulin to the action of norepinephrine on renal prostaglandin synthesis and vascular tone.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1986 Feb; 236(2):424-31. PubMed ID: 3080585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet.
    Sakr HM; Dunham EW
    Am J Physiol; 1982 Jul; 243(1):H61-7. PubMed ID: 6807110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.